TIPELUKAST

TIPELUKAST

Biochem/physiol Actions

Tipelukast is a Leukotriene D4 (LTD4) receptor antagonist and an inhibitor of 5-lipoxygenase (5-LO) and also phosphodiesterases PDE3 and PDE4. It has been found to have antifibrotic and anti-inflammatory activity. Tipelukast has been investigated as a possible treatment for nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3576214 TIPELUKAST white to beige KPWYNAGOBXLMSE-UHFFFAOYSA-N 1S/C29H38O7S/c1-5-9-23-25(14-12-22(20(4)31)29(23)36-16-7-11-27(32)33)35-17-8-18-37-26-15-13-21(19(3)30)28(34)24(26)10-6-2/h12-15,34H,5-11,16-18H2,1-4H3,(H,32,3 SIGMA-ALDRICH
£108.50 (exc VAT) per 1MG
-
+
3576215 TIPELUKAST white to beige KPWYNAGOBXLMSE-UHFFFAOYSA-N 1S/C29H38O7S/c1-5-9-23-25(14-12-22(20(4)31)29(23)36-16-7-11-27(32)33)35-17-8-18-37-26-15-13-21(19(3)30)28(34)24(26)10-6-2/h12-15,34H,5-11,16-18H2,1-4H3,(H,32,3 SIGMA-ALDRICH
£437.36 (exc VAT) per 5MG
-
+